InvestorsHub Logo
Followers 2
Posts 625
Boards Moderated 0
Alias Born 08/23/2013

Re: None

Monday, 04/09/2018 11:30:33 AM

Monday, April 09, 2018 11:30:33 AM

Post# of 1726
This stock tries one's patience, but it appears to be well-run, they appear to have great respect from (and ties to) non-profits, and they seem to be eliminating as much risk as possible from all their licensing deals by getting some proof of efficacy before even spending the first dollar, etc.

It benefits them to get their stock out of being oversold so they have more options, should new opportunities arise on the acquisition side, and while dilution will be a constant until they monetize something from their portfolio, it's certainly not the norm for biotechs to receive zero to negative value for their products (if they're presumed to eventually be very profitable -- and one presumes a women's Viagra cream will garner some interest out there).

I have 31000 shares, for now, and while I likely won't go much higher than that, I simply don't understand how $DARE won't command a $100 million MC once there's some understanding of the good products in its portfolio. So while I may yet sell too early, I won't sell until it seems I'd have given myself at least a 3- or 5-bagger, all of which would make me quite happy to have endured this currently tiring ride.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DARE News